Search

days

 

The 24th CHINA-PHARM & 85th API China:

All rights reserved ©  Reed Sinopharm Exhibitions Co., Ltd.    京ICP备06050757号                                                                                    Website building:Powered By 300.cn Beijing

International Sales and marketing:

Evan Wang 010-84556692

Linkedin

 Mobile

新闻中心

News

Pharmaceutical Production and Marketing Report Series 1: Economic Operation of Chemical Pharmaceutical Industry in 2019

Source:
China Pharmaceutical Industry Association
2020/08/18 16:22
[Abstract]:
Output of China's Pharmaceutical Industry (the First Half of 2020 Version)Series 1: Economic Operation of Chemical Pharmaceutical Industry in 2019.

 

Data from the National Bureau of Statistics showed that the revenue growth of pharmaceutical industry in 2019 was 4.1% higher than the national average. The profits reached a year-on-year growth of 7%. Among the 10 sub-industries of pharmaceutical industry, only the Chinese herbal slice industry decreased in revenue and profit. The growth rates of chemical API and Chinese patent medicine were lower than the industry average.

 

In 2019, the cumulative added value of the pharmaceutical industry Note 1 grew by 6.6% year on year, 3.1% less than that of 2018. The increase in December grew by 5.3% year on year, 0.2% higher than that in November. The operating revenue reached 2614.74 billion RMB, with a year-on-year increase of 8%, and 4.1% higher than the national average. The profit reached 345.7 billion RMB, with a year-on-year increase of 7%. The amount of export delivery reached 211.69 billion RMB, with a year-on-year increase of 7%.

 

In 2019, the operating revenue of chemical pharmaceutical industry Note 2 reached 1237.98 billion RMB, with a year-on-year increase of 9.4%. The profit reached 162.19 billion RMB, with a year-on-year increase of 11.5%. The amount of export delivery reached 91.92 billion RMB, with a year-on-year increase of 4.6%.

 

In 2019, the operating revenue of enterprises mainly producing chemical API reached 380.37 billion RMB, with a year-on-year growth of 5%. The profit reached 44.92 billion RMB, with a year-on-year increase of 4.1%. The export delivery amount increased by 4.6% year on year. Notes and accounts receivable increased by 6.8% year on year, 1.3% less than the industry average. The number of loss-making enterprises decreased by 6, with a loss of 4.36 billion RMB, increasing by 35.2% year on year. The operating profit ratio of enterprises mainly producing API was 11.81%, with a year-on-year decrease of 0.1%.

 

In 2019, the operating revenue of enterprises mainly producing chemical preparations reached 857.61 billion RMB, with a year-on-year increase of 11.5%. The profit reached 117.27 billion RMB, with a year-on-year increase of 14.6%. The export amount of preparations was 20.15 billion RMB, with a year-on-year increase of 4.6%. Notes and accounts receivable increased by 10.3% year on year. The number of loss-making enterprises decreased by 3 year on year, and the amount of loss decreased by 22.3% year on year. The operating profit ratio of enterprises mainly producing chemical preparations was 13.67%, with a year-on-year increase of 0.38%.

 

 

Note 1: The pharmaceutical industry consists of chemical APIs, chemical preparations, Chinese patent medicine, Chinese herbal slices processing, biological drugs manufacturing, genetic engineering drugs and vaccines manufacturing, sanitary materials, pharmaceutical supplies, pharmaceutical excipients and packaging materials, pharmaceutical machinery and medical devices.

Note 2: The chemical pharmaceutical industry consists of chemical APIs and chemical preparations.

 

 

For business contact:

Mr. Evan

Tel: +86 010 8455 6692

Mob: +86 185 1324 5331 (WeChat & Whatsapp)

Email:ye.wang@reedsinopharm.com